Dermapharm Holding SE (DMP.DE) XETRA

38.50

+1(+2.67%)

Updated at December 23 05:37PM

Currency In EUR

Valuation

Market Cap2.09B
Enterprise Value2.95B
P/E Ratio17.86
PEG Ratio2.09
Price/Sales Ratio1.79
Price/Book Ratio3.19
Enterprise/Revenue2.53
Enterprise/EBITDA9.42

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.1
Operating Margin0.19

Management Effectiveness

Return On Assets0.05
Return On Equity0.19

Income Statement

Revenue1.18B
Revenue/Share21.55
Gross Profit767.07M
EBITDA320.91M
Net Income113.79M
Diluted EPS2.11

Balance Sheet

Total Cash146.58M
Total Cash/Share2.72
Total Debt1.01B
Total Debt/Equity1.56
Current Ratio2.2
Book Value Per Share12

Price History

52-Week Change0
52-Week High42.5
52-Week Low31.7
Moving Average 50 Days35.17
Moving Average 200 Days35.1

Statistics

Average Volume30,105
Shares Outstanding53.84M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.9
Trailing Annual Dividend Yield2.34
Payout Ratio0.42
Last Split FactorN/A
Last Split DateN/A